Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A drug for treating allergic purpura

A technology for allergic purpura and drugs, applied in allergic diseases, drug combinations, antipyretics, etc., can solve problems such as major side effects and treatment risks, and achieve the effects of significant curative effect, no drug dependence, and small toxic and side effects

Inactive Publication Date: 2011-12-07
内蒙古自治区中蒙医医院 +1
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

From the characteristics of Henoch-Schonlein Purpura, the disease is likely to involve the gastrointestinal tract, liver, kidney and other organs, so the silver vermilion in the original prescription is not good for this disease, so this prescription has relatively large side effects and treatment risks

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A drug for treating allergic purpura
  • A drug for treating allergic purpura
  • A drug for treating allergic purpura

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Raw materials are prepared according to the following weight proportions: 25 parts of wood beetle seed, 35g of Dijin grass, 50 parts of safflower, 25 parts of bear bile, 25 parts of grass fruit, 35 parts of dry shoot, 38 parts of red sandalwood, 40 parts of lentil flower, and then press The conventional method in this field grinds the raw materials into fine powder, and then beats them into water pills to obtain the product.

Embodiment 2

[0014] Embodiment 2 (drug efficacy test data)

[0015] Effect of medicine of the present invention on normal mouse coagulation time (capillary glass tube method)

[0016] [Purpose]

[0017] To understand the effect of the drug of the present invention on the coagulation time of normal mice, so as to further study the mechanism of action of the drug for treating Henoch-Schonlein purpura.

[0018] [Material]

[0019] Animals: Kunming white mice, secondary cleaning, ♂, weighing 20±2g, purchased from the Experimental Animal Research Center of Inner Mongolia University, certificate number: 8806M35. Equipment: capillary glass tube (inner diameter 1mm, length 10cm, product of Hohhot Science and Technology Development Institute, measurement certificate number: 92 measuring machine character No. 003), stopwatch (Shanghai), etc. Reagent: tested drug-medicine of the present invention, physiological saline, purified water (re-distilled and made).

[0020] [method]

[0021] 1. the pre...

Embodiment 3

[0031] Clinical Trials

[0032] Materials and Methods

[0033] 1.1 Materials

[0034] 1.1.1 Case selection

[0035] A total of 191 children with allergic purpura who were hospitalized in the Department of Hematology and Oncology of Mongolian Medicine Hospital of Inner Mongolia Autonomous Region from September 2005 to December 2006 were randomly divided into observation group and control group, including 93 males and 98 females , for the first onset or first recurrence, and meet the diagnostic criteria.

[0036] 1.1.2 Diagnostic criteria

[0037] It conforms to the diagnostic criteria of the seventh edition of "Practical Pediatrics" edited by Zhu Futang in 2002 (that is, the new diagnostic criteria for allergic purpura formulated by the American Rheumatology Association in 1990). The diagnostic criteria of the sixth edition of the textbook "Internal Medicine" compiled by the school.

[0038] 1.1.3 Clinical materials

[0039] Observation group: 45 males and 50 females, a t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a medicine for treating allergic purpura. 35 parts, 38 parts of red sandalwood, 40 parts of lentil flower. The drug is mainly used for the treatment of allergic purpura, the cure rate can reach more than 95%, and the total effective rate is 98%.

Description

technical field [0001] The invention relates to a medicine for treating allergic purpura, in particular to a Mongolian medicine for treating allergic purpura. Background technique [0002] Allergic purpura is a disease caused by allergens that cause immune inflammation in the walls of small blood vessels in the human body. Purpura on the skin around the body, purpura can cause joint pain and swelling, abdominal pain, blood in the stool, and protein, blood in the urine and other allergic diseases. Also known as Allergic purpura (referred to as AP). At present, the disease has an increasing trend along with various air, water sources, food pollution and improper medication. Due to the accumulation of multiple organs and tissues, the disease has caused multiple physical, psychological and economic burdens to the majority of patients, seriously affecting the physical and mental health of the patients. Children and teenagers have a high prevalence rate of this disease, and it h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61P29/00A61P37/08A61K36/88A61K35/413
Inventor 杭盖巴特尔斯琴高钰思旭日宝音德力格尔
Owner 内蒙古自治区中蒙医医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com